Prurigo pigmentosa: A multi-institutional retrospective study - 15/07/23
Doi : 10.1016/j.jaad.2023.03.034
Amy Shen, BS a, ⁎ 
, Carol E. Cheng, MD a, Rhea Malik, MS b, Erica Mark, BS c, Natalia Vecerek, MD d, Nolan Maloney, MD e, Joan Leavens, MD f, Vinod E. Nambudiri, MD, MBA, EdM b, Art P. Saavedra, MD, PhD c, Marcia Hogeling, MD a, ∗, Scott Worswick, MD d, ∗
, Carol E. Cheng, MD a, Rhea Malik, MS b, Erica Mark, BS c, Natalia Vecerek, MD d, Nolan Maloney, MD e, Joan Leavens, MD f, Vinod E. Nambudiri, MD, MBA, EdM b, Art P. Saavedra, MD, PhD c, Marcia Hogeling, MD a, ∗, Scott Worswick, MD d, ∗ a Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
b Harvard Medical School, Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
c Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia
d Department of Dermatology, University of Southern California, Los Angeles, California
e Department of Dermatology, Stanford University, Palo Alto, California
f Lake Washington Dermatology and Dermatopathology, Kirkland, Washington
∗Correspondence to: Amy Shen, BS, Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095Division of DermatologyDepartment of MedicineDavid Geffen School of Medicine at UCLA10833 Le Conte AveLos AngelesCA90095
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by UCLA (IRB#: 21-000840), Mass General Brigham (IRB#: 2022P001488), and University of Virginia (IRB: #HSR220101). |
|
| Key words: antibiotics; autoimmune; comorbidities; connective tissue disease; diabetes; distribution; doxycycline; general dermatology; hyperlipidemia; ketogenic diet; lupus; medical dermatology; minocycline; papules; papulovesicles; prurigo pigmentosa; rash; reticulated hyperpigmentation; retrospective study; Sjogren; treatment; topical steroids. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 2
P. 376-378 - août 2023 Retour au numéro
Article précédent
- Risk factors for development of skin cancer differ between allogenic and autogenic hematopoietic stem cell transplant recipients
- Chelsea Shope, Laura Andrews, Caroline Brailsford, Lara Wine Lee
- Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review
- Christine Learned, Stephanie R. Cohen, Kaitlynne Cunningham, Sarah Alsukait, Sueheidi Santiago, Jun Lu, Marti Rothe, Anna Nichols, David Rosmarin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?